{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Azizmohammad Looha M"],"funding":["Pediatric Pathology Research Center of Shahid Beheshti University of Medical Sciences, Tehran, Iran","Shahid Beheshti University of Medical Sciences"],"pagination":["e1660"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9875610"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["6(1)"],"pubmed_abstract":["<h4>Background</h4>Pediatric sarcomas are divided into two major groups of soft-tissue sarcomas (STSs) and malignant bone tumors (MBTs).<h4>Aims</h4>The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age, and histological types.<h4>Methods and results</h4>Data was retrieved from Iran National Cancer Registry between 2008 and 2015. The dataset was classified according to the third edition of the International Classification of Childhood Cancer. The survival information was merely available for 291 (21% of total data), including 142 (49%) MBTs and 149 (51%) STSs. The age-standardized incidence rates (ASIRs) and five-year survival rates were calculated.<h4>Conclusion</h4>The present study is"],"journal":["Cancer reports (Hoboken, N.J.)"],"pubmed_title":["Epidemiology of pediatric sarcoma in Iran."],"pmcid":["PMC9875610"],"funding_grant_id":["21217"],"pubmed_authors":["Azizmohammad Looha M","Akbari ME","Khodakarim S","Zarean E","Mehrvar N","Akbari A"],"additional_accession":[]},"is_claimable":false,"name":"Epidemiology of pediatric sarcoma in Iran.","description":"<h4>Background</h4>Pediatric sarcomas are divided into two major groups of soft-tissue sarcomas (STSs) and malignant bone tumors (MBTs).<h4>Aims</h4>The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age, and histological types.<h4>Methods and results</h4>Data was retrieved from Iran National Cancer Registry between 2008 and 2015. The dataset was classified according to the third edition of the International Classification of Childhood Cancer. The survival information was merely available for 291 (21% of total data), including 142 (49%) MBTs and 149 (51%) STSs. The age-standardized incidence rates (ASIRs) and five-year survival rates were calculated.<h4>Conclusion</h4>The present study is","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-21T23:12:54.945Z","creation":"2025-04-05T19:03:21.955Z"},"accession":"S-EPMC9875610","cross_references":{"pubmed":["35761437"],"doi":["10.1002/cnr2.1660"]}}